🌹Affiliation
Open Source Pharma Foundation
🌹Contact
Dr Jaleel UCA
Principal Scientist
OSPF Drug Discovery Lab
🌹Whatsapp 00919349480381
🌹[email protected]
https://newfoundmed.org/people/
🌹Social Media
Jaleel U C in face book & Google
🌹Visiting
🌹Open Source Pharma Open Lab
8 bis Rue Charles V, 75004 AIParis, France
Cheminformatcs🌹Mechine learning🌹 Artificial intelligence in Medchem🌹
🌹 Focus
🌹 Various aspects of cheminformatics, including machine learning and AI-based analysis of neglected tropical diseases like TB, Malaria, and Leishmaniasis. His primary focus is in the application of machine learning and AI models
🌹 successfully applied ANN based machine learning models on the inconclusive molecules of the beta-lactamase bioassays of Mycobacterium tuberculosis.
🌹Past
Principal Investigator of the "Cheminformatics for Neglected Diseases Project" for Open Source Drug Discovery (CSIR Govt of India) was instrumental in building as well as managing the crowdsource and machine learning solutions for various issues in the tropical disease research.
🌹Past
🌹Major contribution includes the solutions for the issues related with higher dimensional analysis and extractions of principal features of the in silico designing of machine learning models.
Past
🌹National Coordinator
TATA CSIR OSDD fellowships
Supported by TATA trust
Task was to mobilise open source programme in health
🌹Past
🌹Worked at CSIR OSDD research unit at Indian Institute of science Bangalore could establish the successful modelling of semiconducting properties by machine learning and higher dimensional correlations of various kinds of datasets.
🌹Recent Publication 2021
A GPU based virtual screening tool using SOM
Description
Authors
PB Jayaraj, KM Mithun, G Gopakumar, UC A Jaleel
2021
Journal
International Journal of Computational Biology and Drug Design
Inderscience Publishers (IEL)
Description
This paper attempts to introduce the applicability of low cost graphics processing unit alternatives to a virtual screening technique using a novel self-organising map (SOM) based technique.
🌹Media
🌹🌹FORBES
https://www.forbesindia.com/article/big-bet/the-collateral-benefits-of-indias-open-source-drug-discovery-programme/37514/1
🌹🌹BBC
https://www.bbc.com/news/business-42188808
🌹🌹🌹
Association &Collabrations
CRI Paris
KEMRI Kenya ( Natural products )
Newfound Medicine( Europe&US )
KAISER
//Dr Vinod Scaria (IGIB Newdelhi)
https://kaiser.genomes.in/epidemicwa
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
June 11, 2024 | 1,315 | +2 | +0.2% |
May 08, 2024 | 1,313 | +1 | +0.1% |
March 06, 2024 | 1,312 | +1 | +0.1% |
February 13, 2024 | 1,311 | +1 | +0.1% |
January 10, 2024 | 1,310 | +10 | +0.8% |
May 26, 2022 | 1,300 | -100 | -7.2% |
September 23, 2021 | 1,400 | +1,371 | +4,727.6% |